EVAg

Lyophilized ready-to-use primers and probe (Lyoph-P&P, 96 rxns in the form of 4x24 rxns) for real time RT-PCR of SARS-CoV-2 (2019-nCoV) as of Jan 30, 2020, available from https://www.mdpi.com/1999-4915/12/2/159/pdf. Primers and Probe sequences designed by Charité Universitätsmedizin Berlin ; https://www.who.int/docs/default-source/coronaviruse/wuhan-virus-assay-v1991527e5122341d99287a1b17c111902.pdf. SOPs in the attached pdf. Disclaimer: This product does not contain the polymerase For RUO (research use only)

Lyophilized ready-to-use primers and probe (Lyoph-P&P, 24 rxns in the form of 3x8 rxns) for real time RT-PCR of SARS-CoV-2 (2019-nCoV) in the RdRp gene. Primers and Probe sequences designed by Charité Universitätsmedizin Berlin. https://www.who.int/docs/default-source/coronaviruse/wuhan-virus-assay-v1991527e5122341d99287a1b17c111902.pdf. SOPs in the attached pdf. Disclaimer: This product does not contain the polymerase For RUO (research use only)

Lyophilized ready-to-use primers and probe (Lyoph-P&P, 96 rxns in the form of 4x24 rxns) for real time RT-PCR of SARS-CoV-2 (2019-nCoV) in the RdRp (IP4) gene. Primers and Probe sequences designed by Institut Pasteur: https://www.who.int/docs/default-source/coronaviruse/real-time-rt-pcr-assays-for-the-detection-of-sars-cov-2-institut-pasteur-paris.pdf?sfvrsn=3662fcb6_2) SOPs in the attached pdf. Disclaimer: This product does not contain the polymerase For RUO (research use only)

Lyophilized ready-to-use primers and probe (Lyoph-P&P, 96 rxns in the form of 4x24 rxns) for real time RT-PCR of SARS-CoV-2 (2019-nCoV) in the N (CUB) gene. Primers and Probe sequences designed by Charité Universitätsmedizin Berlin; https://www.who.int/docs/default-source/coronaviruse/wuhan-virus-assay-v1991527e5122341d99287a1b17c111902.pdf). SOPs in the attached pdf. Disclaimer: This product does not contain the polymerase For RUO (research use only)

SARS-COV-2 Lyophilised RNA, HUMAN, 2021, GERMANY (LINEAGE B.1.351 Beta). Extracted from infectious cell culture supernatant. Product only available via TNA.

SARS-COV-2 Lyophilised RNA, HUMAN, 2022, GERMANY (LINEAGE BA.5, OMICRON). Extracted from infectious cell culture supernatant. Product only available via TNA.

SARS-COV-2 Lyophilised RNA, HUMAN, 2021, GERMANY (LINEAGE B.1.621, Mu). Extracted from infectious cell culture supernatant. Product only available via TNA.

SARS-COV-2 Lyophilised RNA, HUMAN, 2021, GERMANY (LINEAGE B.1.1.318). Extracted from infectious cell culture supernatant. Product only available via TNA.

SARS-COV-2 Lyophilised RNA, HUMAN, 2021, GERMANY (LINEAGE B.1.617.1, Kappa). Extracted from infectious cell culture supernatant. Product only available via TNA.

SARS-COV-2 Lyophilised RNA, HUMAN, 2020, GERMANY (LINEAGE B.1). Extracted from infectious cell culture supernatant. Product only available via TNA.

SARS-COV-2 Lyophilised RNA, HUMAN, 2021, GERMANY (LINEAGE B.1.1.7 Alpha). Extracted from infectious cell culture supernatant. Product only available via TNA.

RNA SARS-CoV-2 strain B.1.617 (India). Product only available via TNA.

This product represents cDNA material, transcribed with random hexamers from total RNA extracted from the viral stock of SARS-CoV-2 strain Slovakia/SK-BMC5/2020 which is available as a viable virus under Ref-SKU: 006V-03933.

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the NTD & RBD (nt 1 to 1572 in the spike coding sequence) of the SARS-CoV-2 alpha variant (B.1.1.7) and can be used as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the NTD & RBD (nt 1 to 1517 in the spike coding sequence) of the SARS-CoV-2 beta variant (B.1.351 )and can be used as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the NTD & RBD (nt 1 to 1581 in the spike coding sequence) of the SARS-CoV-2 BavPat1 strain (D614G) and can be used as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the NTD & RBD (nt 1 to 1581 in the spike coding sequence) of the SARS-CoV-2 delta variant (B.1.617.2) and can be used as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.

The lyophilized, non infectious, encapsidated RNA (Armored RNA) contains the NTD & RBD of the SARS-CoV-2 gamma variant (P.1) and can be used as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. Packaged for 100 Rxns, for RUO (Research Use Only). SOPs in the attached pdf.

Purified RNA of Coronavirus strain "BetaCoV/Germany/BavPat1/2020 p.1" grown in cell culture. Dislaimer: Import permit maybe be needed in your country. If yes, please indicate so in your online enquiry.

In vitro transcribed RNA for Wuhan coronavirus (2019-nCoV) real time (RT-)PCR targeting region of the E gene . Protocol and preliminary evaluation for this assays (Corman/Drosten 2020), as of Jan 13, 2020, available from: https://www.who.int/docs/default-source/coronaviruse/protocol-v2-1.pdf?sfvrsn=a9ef618c_2 Ref: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.3.2000045

In vitro transcribed RNA for Wuhan coronavirus (2019-nCoV) real time (RT-)PCR targeting region of the RdRP gene . Protocol and preliminary evaluation for this assays (Corman/Drosten 2020), as of Jan 13, 2020, available from: https://www.who.int/docs/default-source/coronaviruse/protocol-v2-1.pdf?sfvrsn=a9ef618c_2 Ref: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.3.2000045

In vitro transcribed RNA for a specific SARS-coronavirus real time PCR.

In vitro transcribed RNA for new Betacoronavirus virus (hCoV-EMC) real time PCR targeting region upstream of the E gene (upE). Reference: Corman et. Al., Eurosurveillance, Volume 17, Issue 39, 27 September 2012

In vitro transcribed RNA for new Betacoronavirus virus (hCoV-EMC) real time PCR targeting region within the open reading frame 1a. Reference: Corman/Mueller et al., Eurosurveillance, Volume 17, Issue 49, 06 December 2012

Lyophilized encapsidated RNA for SARS-CoV-2 (2019-nCoV) real time RT-PCR targeting region of the N (CUB) gene, for 100 Rxns (Target designed by Charité Universitätsmedizin Berlin). The encapsidated RNA has been stabilized to serve as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. SOPs in the attached pdf. For RUO (Research Use Only)